Zhejiang Starry Pharmaceutical Co.,Ltd.’s Net Profit Rose 34.1% in First Quarter of 2022

Zhejiang Starry Pharmaceutical Co.,Ltd. (浙江司太立制药股份有限公司) (603520.SH) reported a net profit of 86.6 million yuan in the first quarter of 2022, up 34.1% year-on-year.

Meanwhile, the company posted 517.3 million yuan in revenue, up 42.1% year-on-year.

At the end of the reporting period, it had 5.2 billion yuan in total assets and 2.9 billion yuan in total liabilities, with a liability-to-asset ratio of 55.7%.